Still it has some support but at some point there could be pullback for it as well because it has appreciated lot over the last five years and trading at a PE ratio of over 50.
What do you call a pullback? It has already pulled back from $14 plus.
Ecclesiastes 11:2: “Divide your portion to seven, or even to eight, for you do not know what misfortune may occur on the earth.”
Ben Graham - In the short run the market is a voting machine but in the long run the market is a weighing machine
What do you call a pullback? It has already pulled back from $14 plus.
yawn...you'd have to take another 50% off the price for these 'value investors' to consider it a bargain. Trust me they've been calling it overvalued since $2/share
I picked up some after lunch for $10.12, but only half the order went through. So am hoping that is new low. If not, then maybe buy more tomorrow for 9.99.
The share consolidation has been a bit of a disaster falling from $0.40 (or $0.08 per old share) to about $0.20 (or $0.04 per old share).
No news about the IdeaSphere payment of US$400,000
Classic situation - gloom and despondancy grows around the perception that a small biotech is failing to make revenue targets.
Further, Jim Guthrie has resigned at seeming short notice from the board due to ill health. It seems being an ATM Director is a very hazardous occupation.
More gloom and despondancy that maybe the firm leadership is not stable and strong.
Next opportunity for an information update is the agm on the 29th June.
Prognosis: gloomy with outbreaks of despondancy until either the new strategy seems proven or fails. The share price will either go up significantly or go down significantly - cannot see it staying where it is much longer.
Bookmarks